NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Fluxergy, Mass General Brigham Partner on Rapid COVID-19 Molecular Testing System

Fluxergy is collaborating with Mass General Brigham (MGB) to evaluate Fluxergy's research-use-only COVID-19 molecular-testing platform. Fluxergy will work with the MGB Center for COVID Innovation, which was launched in late March. The so-called Diagnostic Accelerator is a collaboration between the Wyss Institute and Brigham and Women's Hospital that aims to speed up the commercialization of innovative diagnostic tests.

Dr. Ali Tinazli, Chief Commercial Officer

Fluxergy's diagnostic system comprises consumable "lab-on-chip" test cartridges called Fluxergy Cards, the Fluxergy Analyzer and FluxergyWorks software. It can provide results in under an hour, and is designed to be cost-effective and scalable, using proprietary printed circuit-board manufacturing and microfluidics technologies. See Report on Company

To continue reading, please Login or Join